返回
D
David J. Malebranche
gilead sciences, foster city, california, usa
34H指数
110论文数
3.4K被引数
收录论文 27
发表时间
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus-1 (HIV-1): A systematic literature review of clinical and patient-reported outcomes以比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺(B/F/TAF)作为初始治疗的人类免疫缺陷病毒-1(HIV-1)感染者快速启动:一项关于临床结局和患者报告结局的系统文献综述
HIV Medicine
IF3.2

